Evidencia científica
570 artículos revisados por expertos publicados hasta ahora
-
Chronic Antibiotic-Refractory Pouchitis: Management Challenges
-
Successful treatment of pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome with granulocyte and monocyte adsorption apheresis
-
Sa453 THERAPEUTIC EFFICACY OF GRANULOCYTE AND MONOCYTE ADSORPTIVE APHERESIS IS CORRELATED WITH COLONIC MUCOSAL EXPRESSION OF TIGHT JUNCTION MOLECULES IN ULCERATIVE COLITIS
Clinical remission / colon / EGF / gma / GMAs responders / HGF / mucosa / MUCOSAL HEALING / occludin / thight junction molecules / ulcerative colitis / ZO-1 /Continúa
-
S-05-06 Efficacy of Adsorptive Granulocyte/Monocyte Apheresis in Inflammatory Bowel Disease Patients Experiencing Loss of Response to Infliximab (poster)
combination / Crohn's disease / efficacy / gastroenterology / gma / IBD / Infliximab / Loss of response / ulcerative colitis /Continúa
-
S-05-05 Efficacy and safety of cytapheresis in elderly patients with ulcerative colitis (poster)
-
Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19
-
Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trial
-
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
-
Leukocytapheresis for rheumatoid arthritis cases that are super-resistant to any class of biological drugs and tofacitinib
-
Refractory Ulcerative Colitis Improved by Scheduled Combination Therapy of Vedolizumab and Granulocyte and Monocyte Adsorptive Apheresis
-
Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future
-
Leukocytapheresis Therapy for Rheumatoid Arthritis: Results Compared with Control Trial
ContáctanosPara solicitar información adicional
Contáctanos